These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 34746313)

  • 1. Safety and Toxicity Issues of Therapeutically Used Nanoparticles from the Oral Route.
    Lotfipour F; Shahi S; Farjami A; Salatin S; Mahmoudian M; Dizaj SM
    Biomed Res Int; 2021; 2021():9322282. PubMed ID: 34746313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid nanoparticles for oral antimicrobial drug delivery: a review.
    Raza A; Sime FB; Cabot PJ; Maqbool F; Roberts JA; Falconer JR
    Drug Discov Today; 2019 Mar; 24(3):858-866. PubMed ID: 30654055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers.
    Araújo F; Shrestha N; Granja PL; Hirvonen J; Santos HA; Sarmento B
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):381-93. PubMed ID: 25495133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.
    Liu L; Yao W; Rao Y; Lu X; Gao J
    Drug Deliv; 2017 Nov; 24(1):569-581. PubMed ID: 28195032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors.
    Okur NÜ; Siafaka PI; Gökçe EH
    Curr Pharm Biotechnol; 2021; 22(7):892-905. PubMed ID: 32753006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.
    Date AA; Hanes J; Ensign LM
    J Control Release; 2016 Oct; 240():504-526. PubMed ID: 27292178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
    Ensign LM; Cone R; Hanes J
    Adv Drug Deliv Rev; 2012 May; 64(6):557-70. PubMed ID: 22212900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?
    Diab R; Jaafar-Maalej C; Fessi H; Maincent P
    AAPS J; 2012 Dec; 14(4):688-702. PubMed ID: 22767270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
    Yun Y; Cho YW; Park K
    Adv Drug Deliv Rev; 2013 Jun; 65(6):822-32. PubMed ID: 23123292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.
    Sharma M; Sharma R; Jain DK; Saraf A
    Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal.
    Singh G; Pai RS
    Drug Deliv; 2016; 23(2):532-9. PubMed ID: 24963752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
    Singh G; Pai RS
    J Pharm Pharmacol; 2014 Aug; 66(8):1062-76. PubMed ID: 24779896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current applications of solid lipid nanoparticles and nanostructured lipid carriers as vehicles in oral delivery systems for antioxidant nutraceuticals: A review.
    Gunawan M; Boonkanokwong V
    Colloids Surf B Biointerfaces; 2024 Jan; 233():113608. PubMed ID: 37925866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial of Special Issue "Surface-Functionalized Nanoparticles as Drug Carriers".
    Layek B; Singh J
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs.
    Nabi B; Rehman S; Baboota S; Ali J
    AAPS PharmSciTech; 2019 Jan; 20(2):60. PubMed ID: 30623263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia.
    Liu S; Ho PC
    J Pharm Pharmacol; 2017 Nov; 69(11):1495-1501. PubMed ID: 28809432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
    Wang XQ; Zhang Q
    Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocomposite systems for precise oral delivery of drugs and biologics.
    Andretto V; Rosso A; Briançon S; Lollo G
    Drug Deliv Transl Res; 2021 Apr; 11(2):445-470. PubMed ID: 33534107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent update of toxicity aspects of nanoparticulate systems for drug delivery.
    Patnaik S; Gorain B; Padhi S; Choudhury H; Gabr GA; Md S; Kumar Mishra D; Kesharwani P
    Eur J Pharm Biopharm; 2021 Apr; 161():100-119. PubMed ID: 33639254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.